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 Steroids promote the myelination and regeneration in the peripheral nervous system. 
Whereas, little is known about the inducing effects by which the hormones exert their effects 
on Schwann cells differentiation. This could be revealed by the expression of Schwann cell 
markers in adipose-derived stem cells (ADSCs). The purpose of this study was to present the 
effects of progesterone and 17 β-estradiol on the Schwann cell markers in rat ADSCs. The 
mesenchymal stem cell markers (CD73, and CD90) were assayed by flow cytometry. Rat 
ADSCs were sequentially treated with β-mercaptoethanol, and all-trans-retinoic acid, 
followed by a mixture of basic fibrobroblast growth factor, platelet-derived growth factor, 
forskolin and heregulin. In experimental groups, forskolin and heregulin were substituted by 
progesterone and 17 β-estradiol. After induction, the expression of Schwann cell markers P0, 
and S-100 and the cellular immunocytochemical staining positive rate of anti-S100 and anti-
glial fibrillary acidic protein (GFAP) antibodies were compared in the experimental and 
control groups. Progesterone and 17 β-estradiol triggered P0 and S-100 genes expression 
and induced a cellular immunocytochemical staining positive rate of S-100 and GFAP in rats 
ADSCs. Progesterone induced these changes stronger than 17 β-estradiol. Thus, progesterone 
may induce rat ADSCs toward Schwann-like cells by expression of Schwann cell markers and 
is more potent than 17 β-estradiol in the expression of these markers.  
© 2018 Urmia University. All rights reserved. 
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 و نورتسژورپ راثآ هسیاقم71  اتب– ییارحص شوم یبرچ زا قتشم یداینب یاهلولس رد ناوش لولس یاه صخاش نایب رب لویدارتسا 
 هدیکچ 
 بجوم اه دیئورتسا دوبهب تهج اهنومروه نیا ییاقلا راثآ اما .دنوش یم یطیحم یبصع هاگتسد رد یزاسزاب و ندش هنیلیم نایب هطساو هب دناوت یم رما نیا .دنا هدش هتخانش رتمک ناوش یاهلولس زیامت رب ریثات
 و نورتسژورپ راثآ نداد ناشن هعلاطم نیا فده .ددرگ راکشآ یبرچ زا قتشم یداینب یاهلولس رد ناوش یاه لولس یاه صخاش71 اتب-  قتشم یداینب یاهلولس رد ناوش لولس یاه صخاش نایب رب لویدارتسا زا
یمیشنازم یداینب لولس یاه صخاش .دشاب یم ییارحص شوم یبرچ (CD73  وCD90) اتب طسوت ادتبا ییارحص شوم یبرچ زا قتشم یداینب یاهلولس .دنتفرگ رارق یبایزرا دروم یرتموتیسولف شور اب- 
زاب یتسلابوربیف دشر روتکاف زا یطولخم طسوت همادا رد و کیئونیتر دیسا و لوناتاوتپاکرمی،  و نورتسژورپ ،یبرجت یاههورگ رد .دندش رامیت نیلوگره و نیلوکسروف ،تکلاپ زا هدش قتشم دشر روتکاف71 اتب- 
 ناوش لولس یاه صخاش نایب ،ءاقلا زا دعب .دندش نیلوگره و نیلوکسروف نیزگیاج لویدارتساP0  وS-100 ایلگ یلیربیف یدیسا نیئتورپ یتنآ یاه یداب یتنآ ندش تبثم نازیم و( لGFAP)  یتنآ وS-100  هب
 و نورتسژورپ .دنتفرگ رارق هسیاقم دروم دهاش و یبرجت یاههورگ رد ییایمیشوتیسونومیا یزیمآ گنر شور71 اتب–  یاهنژ نایب کیرحت ثعاب لویدارتساP0  وS-100  ندش تبثم نازیم ءاقلا و یزیمآ گنر
 یاه نیئتورپ ییایمیشوتیسونومیاS-100  وGFAP  یاهلولس رد زا شیب نورتسژورپ .دندش ییارحص شوم یبرچ زا قتشم یداینب71  اتب– ًلاامتحا ،نیاربانب .درک ءاقلا ار تارییغت نیا لویدارتسا  نایب اب نورتسژورپ
ه صخاش نیا نایب رد و دوش یم ناوش هبش یاهلولس تمس هب ییارحص شوم یبرچ زا قتشم یداینب یاهلولس یاقلا ثعاب ناوش لولس یاه صخاش هب تبسن ا71  اتب– .تسارتاناوت لویدارتسا 
:یدیلک یاه هژاو 71 ناوش یاهلولس ،یمیشنازم یداینب یاهلولس ،نورتسژورپ ،یبرچ تفاب ،لویدارتسا اتب 
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Introduction 
 
Schwann cell is a principle glia and plays a pivotal role 
in the development, regeneration and maintaining of the 
peripheral nervous system.1,2 Schwann cells release 
neurotrophic factors and involve in peripheral axons 
myelination, directional guidance of neurons, and cellular 
fragments removal.2 Various studies have shown that 
implanted Schwann cells in nerve guidance channels 
improve the advantageous endogenous responses to nerve 
injury and allow nerve regeneration.3-5 However, the 
clinical application of Schwann cells is debatable because it 
is complicated to find enough numbers of Schwann cells.  
Adipose-derived stem cells (ADSCs) are useful in 
regenerative medicine.6 Several recent studies have 
introduced ADSCs as a source of multipotent stem cells 
which can be differentiated into several cell lines.7,8 
Obtaining of ADSCs is easy, and efficient; it shows very low 
donor site morbidity.9 In addition, adipose tissue contains 
more than a thousand-fold more mesenchymal stem cell 
(MSC) compared to bone marrow.10,11 
The MSCs and glial cells are targets for progesterone 
and estrogen.12-15 Schwann cells synthesize and 
metabolize neurosteriods such as progesterone and 17 β-
estradiol and express steroid receptors.16 Neurosteroids 
regulate the expression of myelin proteins and 
transcription factors with a key role in Schwann cells 
physiology and in their myelinating program.16,17 
Progesterone plays a significant function in peripheral 
nerves myelination.17,18 It could improve the formation of 
new myelin sheaths subsequent to the mouse sciatic 
nerve damage.19 In addition, progesterone has promoted 
axons myelination when added to explanted cultures of 
rat dorsal root ganglia,12,19 accelerated the time of 
myelination nitiation and increased the amount of myelin 
synthesis in co-cultures of Schwann cells and sensory 
neurons.20 Estrogens regulate re-myelination and 
promote neuronal survival via expression of growth 
factors by glial cells.21,22 Interestingly, previous study has 
indicated that progesterone stimulates the expression of 
Schwann cell markers in bone marrow MSCs, 13 but the 
stimulating effect of neuroesteroids on the expression of 
Schwann cell markers in ADSCs has not been 
investigated. In the current study, a comparative study of 
the inducing effects of progesterone and 17 β-estradiol 
with a focus on the expression of Schwann cell markers 
in the ADSCs culture was carried out. 
 
Materials and Methods 
 
Isolation and culture of ADSCs. The ADSCs were 
isolated from adult 4-6 weeks old male Wistar rats (n =6). 
Animal experimental procedures were approved by the 
Research Committee of Kashan University of Medical 
Sciences (N:5219, 2010). The rats were euthanized and fat 
  
 pads were removed carefully from inguinal region. The fat 
pieces were washed with phosphate buffered saline (PBS) 
and mechanically dissociated using sterile scalpel blades. 
After removal of debris, the adipose tissue was 
enzymatically digested for 60 min at 37.00 ˚C using 0.50 
mg mL-1 collagenase type I (Sigma-Aldrich, Saint Louis 
USA). The solution was centrifuged to separate the 
floating population of mature adipocytes from the 
pelleted cells of stromal vascular fractions. The 
suspension containing dissociated tissue cells was 
neutralized by the addition of ADSC medium containing 
Dulbecco's modified Eagle medium (DMEM/F12; Gibco, 
Paisley, UK) supplemented with 10% fetal bovine serum 
(FBS; Gibco) and penicillin/streptomycin solution and 
centrifuged at 1000 g for 7 min, re-suspended and 
filtered. The cells were centrifuged and the pellet was re-
suspended in ADSC medium and transferred to a T75 
flask centrifuged at density of 1.00 × 106 cells. The culture 
medium was changed every other day until the cells 
became 80.00% confluent. The cells were incubated at 
37.00 ˚C with 5.00% CO2 and passaged up to three times 
using trypsin- ethylene-diaminetetraacetic acid (EDTA; 
Gibco). 23 Cell viability of the cultured cells in each 
passage was frequently about 95.00%. Cell count was 
determined using a manual hemocytometer (Marienfeld-
Superior, Lauda-Königshofen, Germany). 
Characterization of ADSCs properties. At passages 
3-5, cells were harvested by the addition of 0.20% 
trypsin-EDTA and washed by PBS 3 times. Aliquots were 
incubated with different rat antibodies (CD90, CD45, 
CD73 or VEGFR2)8,23,24 conjugated with fluorescein 
isothiocyanate (Chemicon, Temecula, USA) in dark, at 
room temperature for 45 min. The phenotype of cultured 
was analyzed by flow cytometry using a FACscan 
cytofluorometry (Becton Dickinson, San Jose, USA). 
Differentiation to a Schwann cell-like phenotype. 
The ADSCs medium was removed from the cultures at 
passage 3 and replaced with medium containing 1 mM β-
mercaptoethanol (Sigma) for 24 hr. Then, cells were 
washed and fresh medium supplemented with 35 ng mL-
1 all-trans-retinoic acid (Sigma) was added. After 72 hr, 
cells were washed and the medium was replaced with 
induction medium in 6 different groups: In the first 
group, the cell differentiation medium supplemented 
with 5 ng mL-1 platelet-derived growth factor (PDGF; 
R&D), 10 mL-1 basic fibroblast growth factor (bFGF; 
Gibco), 5.00 μM forskolin (Sigma) and 200 ng mL-1 
heregulin-β (Milipore) was added (positive control 
group); forskolin and heregulin were replaced with 
progesterone (10-6 M; Sigma) respectively in the second 
and third groups and 17 β-estradiol (10-6 M; Sigma ) 
respectively in the fourth and fifth groups. In the sixth 
group (negative control group), the medium contained 
only 5 ng mL-1 PDGF and 10 ng mL-1 bFGF. The cells 
cultures were followed by incubation for eight days.13 
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Semi-quantitative reverse transcription polymerase 
chain reaction (RT-PCR). Following the differentiation 
period, total RNA was extracted with RNX plus (Ceinna-
Gen, Tehran, Iran). Complementary DNA (cDNA) synthesis 
was carried out from total RNA using Fermentas kit 
(Fermentase, Waltham, USA) based on the manufacturer's 
instructions. The cDNA was amplified using the primers 
designed for S-100 and P0 genes (Table 1). Each 12.50 µL 
PCR reaction mixture included 0.25 µL of each primer, 
0.25µL dNTP, 0.38 µL MgCl2, 0.08 µL taq DNA polymerase, 
1.25 µL 10 × PCR buffer (Fermentas) and 9.30 µL 
ultrapure H2O. BioRad thermocycler was used for PCR 
with the following program: 94 ˚C for 30 sec, 35 cycles at 
94 ˚C for 45 sec, 55 ˚C for 45 sec 72 ˚C for 45 sec, and a final 
extension at 72 ˚C for 10 min. 10 µL of the PCR product 
was separated, in a 1.50% agarose gel and stained with 
ethidiumbromide. The results were expressed relative to 
the housekeeping gene control glyceraldehyde-3-
phosphate dehydrogenase (GAPDH).23 
 
 
 
 
 
 
 
 
 
Immunocytochemistry. The ADSCs of different groups 
were digested by trypsin-EDTA, and seeded into 24 cell 
plates following centrifugation and collection. Then, the 
cells were incubated at 37 ˚C, washed with PBS, dried and 
fixed in 4.00% paraformaldehyde for 20 min. Following 
permeablization using 0.40% Triton X-100 and blocking 
by 5.00% normal goat serum, the cells were incubated 
with primary antibodies against S-100 (1:100; Sigma), or 
GFAP (1:100; Sigma) at 4 °C for 1 hr. After washing, the 
cells incubated with FITC-conjugated anti-rabbit IgG 
(1:100; Sigma) for 45 min at room temperature. The 4ʹ6ʹ-
diamidino-2-phenylondole dihydro-chloride (DAPI) was 
used to determine the nuclei as a counterstain. Finally, the 
cells were examined using an inverted fluorescence 
microscope (Eclipse Ti-S; Nikon, Tolyo, Japan) and the 
percentage of immuno-positive cells was calculated in five 
randomly selected fields at 40× magnification. 
Statistical analysis. The data were analyzed using 
one-way ANOVA and Tukey's post-hoc test and the results 
were expressed as mean ± standard deviation. A p-values 
less than 0.05 was considered statistically significant. 
 
Results 
 
Adipose tissue was enzymatically digested and 
stromal cells were isolated. The cells were cultured and 
after 4 to 5 days, they proliferated rapidly and their  
  
 
 condensation reached to approximately 80.00 to 90.00%. 
The cultured cells exhibited fibroblast-like morphology 
in microscopic observations. 
Most of MSCs were negative for the expression of CD45 
and VEGFR2 but they were positive for CD90 and CD73 
expression. These data demonstrated the mesenchymal 
nature of the isolated cells. 
Differentiation. The ADSCs expressed low levels of 
S-100, and P0 mRNAs. The ADSCs at passage three were 
treated with a mixture of glial growth factors containing 
FGF, PDGF, forskolin, and heregulin for a period of one 
week. This treatment increased the expression of 
Schwann cell markers (S-100 and P0) intensely at 
mRNA level. Progesterone (groups 2 and 3) or 17 β-
estradiol (groups 4 and 5) increased these markers 
compared to the negative control group (group 6). The 
expression of S-100 mRNA in ADSCs in the 
differentiation media containing progesterone and 
heregulin (groups of 1-3) was significantly higher than 
other groups (p < 0.0001), (Fig. 1). 
The expression level of P0 in the presence of 
progesterone and heregulin was near to positive control 
group (Fig. 2).  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. A) A representative result of S100 mRNA expression in 
differentiation groups by RT-PCR. Lane 1: Group 1 (bFGF + PDGF 
+ Forskoin + Heregulin); Lane 2: Group 2 (bFGF + PDGF + 
Heregulin + Progesterone); Lane 3: Group 3 (bFGF + PDGF + 
Forskoin + Progesterone); Lane 4: Group 4 (bFGF + PDGF + 
Heregulin + Estradiol); Lane 5: Group 5 (bFGF + PDGF + Forskoin 
+ Estradiol); Lane 6: Group 6 (bFGF + PDGF); M: Marker. B) a: 
Significant difference with 1st group (positive control group), 
(p < 0.0001); b: Significant difference with other experimental 
groups (p < 0.0001).  
 
Table 1. Primer sequences used for the RT-PCR. 
Gene Primers Size (bp) 
P0 
Forward: CTTCCAAAGGCTCTCAGGTG 
Reverse: ACGGTCACTTGTTCG AGTCC 153 
S100 
Forward: ATAGCACCTCCGTTGGACAG 
Reverse: TCGTTTGCACAGAGGACAAG 169 
GAPDH 
Forward: TTAGCACCCCTGGCCAAGG 
Reverse: CTTACTCCTTGGAGGCCATG 531 
 
310 
 
H. Naderain et al. Veterinary Research Forum. 2018; 9 (4) 307 - 313 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. A) A representative RT-PCR analysis and data of P0 mRNA 
expression in differentiation groups. Lane 1: Group 1 (bFGF + 
PDGF + Forskoin + Heregulin); Lane 2: Group 2 (bFGF + PDGF + 
Heregulin + Progesterone); Lane 3: Group 3 (bFGF + PDGF + 
Forskoin + Progesterone); Lane 4: Group 4 (bFGF + PDGF + H 
Lane eregulin + Estradiol); 5: Group 5 (bFGF + PDGF + Forskoin + 
Estradiol); Lane 6: Group 6 (bFGF + PDGF); M: Marker. B) a: 
Significant difference with 3rd group, (p < 0.001); b: Significant 
difference with 5th group, (p < 0.007); c: Significant difference 
with 4th and 6th groups (p < 0.0001); d: Significant difference with 
1st group, (p < 0.001); e: Significant difference with 4th and 6th 
groups, (p < 0.0001); f: Significant difference with 1st group, (p < 
0.0001); g: Significant difference with 4th and 6th groups, (p < 
0.0001); h: Significant difference with 1st group, (p < 0.004). 
 
In immunocytochemistry experiment, S-100 and GFAP 
positive cells were counted in five fields under fluorescent 
microscope. The undifferentiated cells of the control group 
had no expression of S-100 and GFAP. The staining 
intensity of S-100 and GFAP of cells in groups 2 to 5 
(experimental groups) was more strongly positive than 
that of cells in group 6 (negative control group). In group 2 
(in the presence of progesterone and heregulin), mean 
number of the S-100 and GFAP staining positive cells was 
20.00 ± 5.29 and 18.30 ± 1.15, respectively. In group 3 (in 
the presence of progesterone and forskolin) mean number 
of the S-100 and GFAP staining positive cells was 21.30 ± 
6.50 and 18.30 ± 1.15, respectively. In group 4 (in the 
presence of 17 β-estradiol and heregulin), mean number of 
the S-100 and GFAP staining positive cells was 20.30 ± 
2.80 and 20.30 ± 1.15, respectively. In group 5 (in the 
presence of 17 β-estradiol and forskolin), mean number of 
the S-100 and GFAP staining positive cells was 25.30 ± 
4.70 and 11.60 ± 3.50, respectively. 
 
 
 
 
 
 
 
 Immunocytochemistry showed that the expressions of 
S-100 and GFAP in the experimental groups were 
significantly superior to those of the negative control 
group (group 6), (p < 0.0001). Also, the GFAP proteins 
were significantly expressed higher in the cytoplasm of 
group 4 cells than group 5 cells (p < 0.001), (Figs. 3 and 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. A, and B) Quantitative analysis of morphology and 
expression of S100 (I), and GFAP (II) proteins. a: Significant 
difference with 1st group, (p < 0.0001); b: Significant difference 
with 6th group, (p < 0.0001); c: Significant difference between 4th 
and 5th groups (p < 0.001). 
 
Discussion 
 
The purpose of this study was to examine the inducing 
effects of progesterone and 17 β-estradiol on expression of 
Schwann cell markers in ADSCs. According to the results of 
present study, treatment of ADSCs with progesterone or 
17 β-estradiol could induce the expression of Schwann cell 
markers. 
Adipose tissue contains a high number of multipotent 
MSCs which are able to differentiate into different cells. 
The ADSCs are useful for a range of therapeutic 
applications such as treatment of peripheral nerve 
injuries.25-27 Several experiments have indicated that 
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ADSCs can be differentiated into a Schwann cell 
phenotype as well.28-30 Dezawa et al. differentiated bone 
marrow separated MSCs into myelinating cells with the 
ability to induce nerve regeneration.31 This method is 
based on the effect of a variety of inducers that used one 
by one.32 Our experiment showed that the sequential 
administration of various factors β-mercaptoethanol and 
retinoic acid, followed by a mixture of bFGF, PDGF, 
forskolin and hereguiln is more efficient than other 
inducer mixtures and confirmed Dezawa method. The 
combination of β-mercaptoethanol and retinoic acid in 
culture media is an appropriate pre-inducer21 and a 
mixture of bFGF, PDGF, forskolin and hereguiln has a 
synergistic effect on Schwann cell differentiation.31 In 
Schwann cell development process, forskolin can 
increase the level of intracellular cyclic adenosine 
monophosphate (cAMP) causing cells response to the 
trophic factors leading to myelin marker of P0 mRNA 
expression.33,34 Hereguiln, a subtype of neuregulin, is one 
of the crucial axon-derived signals influencing Schwann 
cells development.35  
Neurosteriods involve in the regulation of Schwann 
cells proliferation and their cellular products.36-38 
Progestins have the ability to activate heregulin receptors 
of ErbB2 and ErbB3.39 In the present study, forskolin and 
heregulin were replaced by progesterone and 17 β-
estradiol. Among the various Schwann markers, we 
particularly focused on P0, S-100, and GFAP. In our 
experiment, P0, a representation marker of myelinating 
cells, was expressed in ADSCs in the presence of 
progesterone. Melcangi et al. have showed that the 
expression of P0 is under the control of progesterone 
receptor and progesterone increases its expression in rat 
Schwann cell culture.40,41 Our data support those of Roglio 
et al. that suggesting that progesterone may be necessary 
for inducing P0 synthesis.16  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Due to estrogen function in tissue and organ 
development through regulating cell proliferation and 
differentiation, we hypothesized that 17 β-estradiol induces 
expression of Schwann cell markers in ADSCs. Based on 
our results, S-100, P0, and GFAP were expressed 
significantly in 17 β-estradiol groups (the fourth and fifth 
groups). The MSCs are anabolic targets of estrogen action, 
via estrogen receptor α activation.42 17 β-estradiol induces 
an earlier onset of axonal regeneration and myelination.43 
The estradiol alone had no effect on cell multiplication, but 
in the presence of forskolin it became a potent mitogen.36 
In the present study, in the fifth group, 17 β-estradiol in 
the presence of forskolin could induce a significantly 
higher expression of P0 mRNA compared to the forth 
group. It seems that estradiol becomes an inducer for 
ADSCs when levels of cAMP are elevated.44 However, in 
our study, 17 β-estradiol was a weaker inducer compared 
to progesterone for expression of Schwann cell markers in 
ADSCs. Higher expression of GFAP protein positive cells in 
the presence of 17 β-estradiol and heregulin than 
combination of 17 β-estradiol and forskolin is evidence for 
the role of heregulin in induction of ADSCs. Dezawa et al. 
believed that no growth factors can be a substitute for 
heregulin in Schwann cell differentiation.31 
Our study showed that progesterone has an inducing 
effect similar to that of heregulin and forskolin in 
expression of Schwann cell markers. This is consistent 
with the study of Movaghar et al. that showing that 
progesterone could induce the transdifferentiation of bone 
marrow stem cells (BMSCs) into Schwann cell 
phenotype.13 It seems that the combinations of heregulin 
and forskolin,31 forskolin and progesterone13 or heregulin 
and progesterone (present study) have cumulative effects 
in the differentiation of MSCs into Schwann-like cell 
phenotype. However, in contrast to Movaghar et al., the 
strongest expression of Schwann cell markers was not 
  
Fig. 4. A - D: Anti-GFAP immunostaining in different groups; E- H: Anti-S100 immunostaining in different groups. A and E: Group 2 (bFGF + 
PDGF + Heregulin + Progesterone); B and F: Group 3 (bFGF + PDGF + Forskoin + Progesterone); C and G: Group 4 (bFGF + PDGF + 
Heregulin + Estradiol); D and H: Group 5 (bFGF + PDGF + Forskoin + Estradiol), Bar = 200 µm. 
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seen in groups treated with progesterone, but it was seen 
in group 1 treated with heregulin and forskolin. Owing to 
the differences in the immunophenotype, transcriptome, 
proteome, and immunomodulatory activity, BMSCs and 
ADSCs have diverse potential in differentiation into variety 
of cells.6,45,46 Although it has been shown that heregulin is 
able to induce progesterone receptor activation47 it seems 
that the combination of heregulin and progesterone 
induces BMSCs and ADSCs through different pathways.  
In conclusion, we induced the rat ADSCs by 
progesterone and 17 β-estradiol in vitro and demonstrated 
the expression of Schwann cell markers. There are still 
some limitations in identification of the Schwann cell 
markers, hence further studies on the induction 
mechanism of progesterone and estradiol and 
differentiation of ADSCs into Schwann-like cell phenotype 
are recommended. 
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